Are we talking about the drug that todays USA Today says Lilly hopes to submit it for regulatory approval in 2014? Sorry I haven't kept up on my dd as I should after owning this for now almost 7 years. Seems to be a reason to stash some more but after buying at 4 years ago and living through the torture I'm skeptical.
Regarding LLY LFRP drugs, from Q1 Dyax Earnings Call Transcript:
For Dyax, the potential of these programs is significant. Following approval, we are eligible to receive a 2% to 3% royalty on the first ten years of commercial sales. Given the size of the markets being targeted, this could amount to significant future revenues being generated.